Organon (OGN) Operating Margin Growth (5y) (2025 - 2026)
Organon (OGN) Operating Margin Growth (5y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.73 Bn | 631.97 Bn | 17.26 Bn |
| 2 | AbbVie | 469.89 Bn | 463.32 Bn | 12.70 Bn |
| 3 | Merck | 377.61 Bn | 370.47 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.24 Bn | 295.55 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.81 Bn | 252.91 Bn | 12.86 Bn |
| 6 | Amgen | 237.20 Bn | 223.21 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.20 Bn | 179.02 Bn | 6.22 Bn |
| 8 | Pfizer | 159.71 Bn | 148.02 Bn | 10.94 Bn |
| 9 | Gsk | 106.41 Bn | 102.24 Bn | 8.24 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,989.00 |
| Mar 31, 2026 | 2,433.00 |
| Dec 31, 2025 | 1,772.00 |
| Sep 30, 2025 | 1,330.00 |
| Jun 30, 2025 | 447.00 |
| Mar 31, 2025 | -139.00 |